Analysis

COVID-19 A data perspective

COVID-19: A data perspective: Explore key economic trends and social challenges that arise as the COVID-19 situation evolves.

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Year of publication

2 facets displayed. 0 facets selected.

Author(s)

2 facets displayed. 1 facets selected.

Survey or statistical program

1 facets displayed. 1 facets selected.
Sort Help
entries

Results

All (2)

All (2) ((2 results))

  • Articles and reports: 88-003-X20030026561
    Geography: Canada
    Description:

    Nanotechnology is an emerging technology. Has it reached the point that warrants the development of a comprehensive statistical measurement program? If so, what indicators should be used? Major spending initiatives in nanotechnology investing are currently underway. There is precedence for using developed methods and techniques to address the questions 'who,' 'what,' 'where' and 'why.' Statistics Canada's experience may be invaluable in the development of a nanotechnology statistical program.

    Release date: 2003-06-27

  • Articles and reports: 88-003-X20020016152
    Geography: Canada
    Description:

    The Biotechnology Use & Development Survey-1999 provides insights into the transition from R&D to the commercial use of a technology in products and processes. Improvement in product quality is reported as the number one benefit derived from using biotechnologies. This article explores some of the characteristics of the firms that use biotechnologies addressing the questions: "Why use biotechnology?" and "Why not use biotechnology?"

    Release date: 2002-02-15
Stats in brief (0)

Stats in brief (0) (0 results)

No content available at this time.

Articles and reports (2)

Articles and reports (2) ((2 results))

  • Articles and reports: 88-003-X20030026561
    Geography: Canada
    Description:

    Nanotechnology is an emerging technology. Has it reached the point that warrants the development of a comprehensive statistical measurement program? If so, what indicators should be used? Major spending initiatives in nanotechnology investing are currently underway. There is precedence for using developed methods and techniques to address the questions 'who,' 'what,' 'where' and 'why.' Statistics Canada's experience may be invaluable in the development of a nanotechnology statistical program.

    Release date: 2003-06-27

  • Articles and reports: 88-003-X20020016152
    Geography: Canada
    Description:

    The Biotechnology Use & Development Survey-1999 provides insights into the transition from R&D to the commercial use of a technology in products and processes. Improvement in product quality is reported as the number one benefit derived from using biotechnologies. This article explores some of the characteristics of the firms that use biotechnologies addressing the questions: "Why use biotechnology?" and "Why not use biotechnology?"

    Release date: 2002-02-15
Journals and periodicals (0)

Journals and periodicals (0) (0 results)

No content available at this time.

Date modified: